Quang X. Pham

Quang X. Pham has been a war child refugee, a combat Marine veteran, top-producing biotech salesman, and successful serial entrepreneur. As a perpetual underdog, he is the first American of Vietnamese heritage to become a US Marine aviator and lead a biotech IPO on Nasdaq (CVKD) – Cadrenal Therapeutics, a biopharmaceutical company developing tecarfarin, a novel blood thinner for patients with rare cardiovascular conditions. He is also the author of A Sense of Duty: Our Journey from Vietnam to America and has received the EY Entrepreneur Of The Year® award.